Lisa G Wolf
CIK 1861556 · COO & CFO · last filed 2026-09-24
Lisa G Wolf is a COO & CFO who has filed 16 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for VBIO, was dated Sep 24, 2026. Across all open-market trades the lifetime net is −$83.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $23 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RESN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
47685 LAKEVIEW BLVD.
FREMONT, CA 94538
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VBIO | COO & CFO | 27 | $0.87 | $23 | $0 | 2 | 2026-09-24 |
| Valion Bio, Inc. (TIVC) Delisted | Chief Financial Officer | 526 | $1.40 | $736 | $0 | 5 | 2026-03-19 |
| Resonant Inc (RESN) Delisted | Chief Accounting Officer | 0 | $4.48 | $0 | -$83.1K | 9 | 2022-03-28 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-24 | VBIO | Mixed | +2 | -$4 | EDGAR |
| 2026-06-18 | VBIO | Exer (M) | +92 | $0 | EDGAR |
| 2026-03-19 | Valion Bio, Inc. (TIVC) Delisted | Exer (M) | +92 | $0 | EDGAR |
| 2025-12-22 | Valion Bio, Inc. (TIVC) Delisted | Mixed | +434 | -$565 | EDGAR |
| 2025-08-22 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-08-08 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-20 | Valion Bio, Inc. (TIVC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-28 | Resonant Inc (RESN) Delisted | Mixed | −170,608 | -$767.7K | EDGAR |
| 2022-01-19 | Resonant Inc (RESN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-03 | Resonant Inc (RESN) Delisted | Mixed | +21,827 | -$32.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.